Nuclear factor-kappaB and tumor-associated macrophages.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Alessandra Mancino, Toby Lawrence

Abstract

Tumor-associated macrophages (TAM) have been linked with the progression of cancer by favoring tumor angiogenesis, growth, and metastasis. The precise mechanisms that maintain the protumor phenotype of TAM are poorly understood, but recent research has highlighted a number of signaling pathways that are important in TAM phenotype and function. Nuclear factor-kappaB (NF-kappaB) is considered the master regulator of inflammatory and immune responses. Recently several genetic studies have indicated NF-kappaB is an important pathway in TAM for the integration of signals from the tumor microenvironment that promote carcinogenesis. This review will focus on the role of NF-kappaB in TAM and the potential of targeting this pathway as a novel therapeutic strategy against cancer.

Citations

Aug 28, 2010·Cancer Metastasis Reviews·Limin ShuAh-Ng Kong
Aug 26, 2010·Targeted Oncology·Mustafa Aziz HatibogluAmy B Heimberger
Sep 11, 2013·Journal of Natural Products·Acharavadee PansanitPrasat Kittakoop
Aug 23, 2011·AIDS Research and Human Retroviruses·Susan F PlaegerAlan Embry
Jul 30, 2010·Neuro-oncology·Adam WuAmy B Heimberger
Oct 6, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Ling-Yuan KongAmy B Heimberger
Oct 16, 2012·Fibrogenesis & Tissue Repair·Loris R LopetusoTheresa T Pizarro
Nov 5, 2014·BMC Complementary and Alternative Medicine·Haixing YangYonghua Wang
Sep 8, 2015·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Myung Shin KimChoon-Sik Park
Jan 15, 2013·Blood Cells, Molecules & Diseases·Agata A FilipAnna Dmoszyńska
Nov 2, 2012·Immunology·Xiaoqiang TangHengyi Xiao
Apr 11, 2012·Journal of Surgical Oncology·Hui WuShi-Rong Cai
Feb 8, 2013·Diabetes/metabolism Research and Reviews·P MatafomeR Seiça
Sep 14, 2016·Oncoimmunology·Kevin BerthenetGaetan Jego
Dec 3, 2014·American Journal of Preventive Medicine·Punam Ohri-VachaspatiFrank J Chaloupka
Jun 25, 2016·Marine Drugs·Kathrin BeckerJohanna M Gostner
Apr 7, 2017·Diagnostic Pathology·Maria Noel Marzano Rodrigues PetruzziMaria Antonia Zancanaro de Figueiredo
Feb 28, 2018·Frontiers in Immunology·Aditi SharmaMrigank Srivastava
Jun 25, 2010·Journal of Leukocyte Biology·Subhra K Biswas, Claire E Lewis
Aug 16, 2017·Proceedings of the National Academy of Sciences of the United States of America·Hisashi KanemaruShizuo Akira
Jul 15, 2015·International Journal of Clinical Oncology·Kenji OmaeKazunari Tanabe
Oct 11, 2011·Cellular and Molecular Life Sciences : CMLS·Rui-Cheng Ji
Aug 1, 2012·Frontiers in Biology·Yonggang Zhang, Wenhui Hu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.